OmniAsset
Get app

OmniAsset › Mutual funds › Nippon India Pharma Fund

Nippon India Pharma Fund

Sectoral / Thematic fund benchmarked to BSE Healthcare TRI. Every figure below is read from one dated snapshot; what the snapshot cannot prove is left out, never estimated.

Latest NAV2 Sep 2026575.0147
CategorySectoral / Thematic
PlanRegular · Growth
Launched10 May 2004
Risk labelthe scheme's own riskometerVery High
Legal benchmarkSEBI Tier-1BSE Healthcare TRI
Expense ratiodirect plan, a year · stated maximum, from the scheme document1.84%
AUM₹6,021 Cr
Growth of ₹10,000₹18,2052 Sep 2021 to 2 Sep 2026
₹18,396₹15,815₹13,234₹10,653₹8,072Sep 2021Nov 2022Mar 2024Jun 2025Sep 2026
₹18,205 (+12.7% a year) Nippon India Pharma Fund

Performance (trailing, annualised)

1Y annualised13.11%
3Y annualised18.59%
5Y annualised12.73%
10Y annualised14.83%

Point-to-point from the fund's own published NAV; a period the history does not span is left out.

SIP returns

SIP 1Y (₹10,000 a month)invested ₹1,20,000 → worth ₹1,33,34321.16%
SIP 3Y (₹10,000 a month)invested ₹3,60,000 → worth ₹4,41,66413.73%
SIP 5Y (₹10,000 a month)invested ₹6,00,000 → worth ₹9,18,47117.05%

₹10,000 on the first of every month, valued at the latest NAV, as an annualised rate (XIRR).

Calendar years

Calendar 202123.93%
Calendar 2022-9.90%
Calendar 202339.15%
Calendar 202434.04%
Calendar 2025-3.34%

Rolling returns

Rolling 1Y · average1002 windows since 5 Apr 200722.15%
Rolling 1Y · median13.88%
Rolling 1Y · worst window-37.64%
Rolling 1Y · best window175.98%
Rolling 1Y · windows positive76%
Rolling 3Y · average898 windows since 9 Apr 200920.05%
Rolling 3Y · median20.98%
Rolling 3Y · worst window-2.02%
Rolling 3Y · best window48.29%
Rolling 3Y · windows positive96%
Rolling 5Y · average795 windows since 7 Apr 201118.88%
Rolling 5Y · median18.29%
Rolling 5Y · worst window-0.39%
Rolling 5Y · best window39.18%
Rolling 5Y · windows positive100%

Every window of that length in the published history, so one lucky start date cannot flatter the fund.

Risk

Volatility (3Y)12.96%
Downside deviation (3Y)8.93%
Maximum drawdown-14.84%

Management

Fund managerSailesh Raj Bhan
Managing since10 Jun 2022

Related

Source: the OmniAsset signed reference snapshot, as of 4 Sep 2026. Figures are deterministic; missing data is withheld, never estimated. See methodology and data sources. Not investment advice.

Research this fund and compare it — on your device.

Get OmniAsset on Google Play The mutual fund tracker